Drug intelligence / Profile preview

panepoxydone

Development stage
Preclinical
Lead developer
University of South Alabama
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Panepoxydone is a natural epoxycyclohexenone compound originally isolated from the basidiomycete fungus *Lentinus crinitus* (and also found in *Panus rudis*). It acts as an inhibitor of the NF-κB signaling pathway by preventing the phosphorylation and subsequent degradation of IκBα, thereby blocking the nuclear translocation of NF-κB. Additionally, panepoxydone has been shown to down-regulate the oncogenic transcription factor FOXM1, leading to a reversal of the epithelial-to-mesenchymal transition (EMT). Preclinical research, primarily led by the Mitchell Cancer Institute at the University of South Alabama, has demonstrated that panepoxydone exerts significant antitumor, anti-proliferative, and pro-apoptotic activity against breast cancer cells, particularly triple-negative breast cancer (TNBC) subtypes. It also exhibits antimicrobial properties and inhibits trypanothione reductase in *Trypanosoma cruzi*.

Other names
Antibiotic SL-3042PP
02

Targets

FOXM1 (Forkhead box protein M1)NF-κBTrypanothione reductase

Beyond the preview

Go deeper on panepoxydone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on panepoxydone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call